Literature DB >> 17142527

Direct medical costs of bronchiolitis hospitalizations in the United States.

Andrea J Pelletier1, Jonathan M Mansbach, Carlos A Camargo.   

Abstract

OBJECTIVES: Although bronchiolitis is the leading cause of hospitalization for infants, there are limited data describing the epidemiology of bronchiolitis hospitalizations, and the associated cost is unknown. Our objective was to determine nationally representative estimates of the frequency of bronchiolitis hospitalizations and its associated costs. PATIENTS AND METHODS: We analyzed the 2002 Health Care Utilization Project-National Inpatient Sample, a federal, stratified random survey of hospital discharges. For admissions age < 2 years with a discharge diagnosis of bronchiolitis (International Classification of Diseases, Ninth Revision, Clinical Modification, code 466.1), we used nationally representative weighted estimates to determine frequency and total hospital charges. Costs were estimated from reported charges by applying hospital-specific cost/charge ratios based on all-payer inpatient cost.
RESULTS: In 2002, an estimated 149,000 patients were hospitalized with bronchiolitis. Frequency of hospitalizations was higher among children age < 1 year of age, male gender, and nonwhite race. Mean length of stay was 3.3 days. Total annual costs for bronchiolitis-related hospitalizations were 543 million dollars, with a mean cost of 3799 dollars per hospitalization. Mean cost of bronchiolitis with a codiagnosis of pneumonia was 6191 dollars. In a multivariate analysis controlling for 3 confounding factors (including length of stay), cost per hospitalization was higher for children > or = 1 year and lower for those in the South versus Northeast.
CONCLUSIONS: Bronchiolitis admissions cost more than 500 million dollars annually. A codiagnosis of bronchiolitis and pneumonia almost doubles the cost of the hospitalization. Inpatient health care costs of bronchiolitis are higher than estimated previously and highlight the need for initiatives to safely reduce bronchiolitis hospitalizations and thereby decrease health care costs.

Entities:  

Mesh:

Year:  2006        PMID: 17142527     DOI: 10.1542/peds.2006-1193

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  65 in total

1.  Child Poverty, Toxic Stress, and Social Determinants of Health: Screening and Care Coordination.

Authors:  Lucine Francis; Kelli DePriest; Marcella Wilson; Deborah Gross
Journal:  Online J Issues Nurs       Date:  2018-09-30

Review 2.  The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses.

Authors:  Martin L Moore; Kate L Stokes; Tina V Hartert
Journal:  Curr Opin Immunol       Date:  2013-12       Impact factor: 7.486

3.  Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season.

Authors:  Pedro A Piedra; Jonathan M Mansbach; Alan M Jewell; Sneha D Thakar; Cameron C Grant; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

4.  Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?

Authors:  William A Prescott; David J Hutchinson
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

5.  Surgical volume, hospital quality, and hospitalization cost in congenital heart surgery in the United States.

Authors:  Titus Chan; Jaewhan Kim; L LuAnn Minich; Nelangi M Pinto; Norman J Waitzman
Journal:  Pediatr Cardiol       Date:  2014-08-07       Impact factor: 1.655

6.  Are we too passive in our attempts to prevent respiratory syncytial virus infection in Northern Canada?

Authors:  Theo Moraes
Journal:  Can Respir J       Date:  2014 May-Jun       Impact factor: 2.409

Review 7.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  A prospective randomised trial comparing nasogastric with intravenous hydration in children with bronchiolitis (protocol): the comparative rehydration in bronchiolitis study (CRIB).

Authors:  Ed Oakley; Franz E Babl; Jason Acworth; Meredith Borland; David Kreiser; Jocelyn Neutze; Theane Theophilos; Susan Donath; Mike South; Andrew Davidson
Journal:  BMC Pediatr       Date:  2010-06-01       Impact factor: 2.125

9.  Compliance with RSV prophylaxis: Global physicians' perspectives.

Authors:  Kari S Anderson; Victoria M Mullally; Linda M Fredrick; Andrew L Campbell
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

10.  Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.

Authors:  Jonathan M Mansbach; Carlos A Camargo
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.